Cantitate/Preț
Produs
Total produse
Vezi coșul
Cell Signaling & Molecular Targets in Cancer de Malay Chatterjee

Cell Signaling & Molecular Targets in Cancer

Editat de Malay Chatterjee, Khosrow Kashfi
en Limba Engleză Paperback – 2 mar 2014
This book provides an overview of critical components of cell signaling machinery and its role in epithelial morphogenesis, proliferation, invasions and angiogenesis in human cancer and discusses novel types of protein kinase pathways.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107995 lei  6-8 săpt.
  Springer – 2 mar 2014 107995 lei  6-8 săpt.
Hardback (1) 108263 lei  6-8 săpt.
  Springer – dec 2011 108263 lei  6-8 săpt.

Preț: 107995 lei

Preț vechi: 113678 lei
-5% Nou

Puncte Express: 1620
Preț estimativ în valută:
20668€ • 21532$ • 17184£

Carte tipărită la comandă

Livrare economică 11-25 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781489993939
ISBN-10: 1489993932
Pagini: 340
Ilustrații: XII, 328 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.52 kg
Ediția:2012
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Acknowledgement.- GRB2 Signaling as a Molecular Target for Cancer.- Human arylamine N-acetyltransferase 1 : from drug metabolism to drug target.- Targeting Argininosuccinate Synthetase in Cancer Therapy.- Parathyroid hormone-related peptide signaling in cancer.- Signaling Molecules as Selective Targets for Therapeutic Strategies in Multiple Myeloma.- Role of Bile Acids in Carcinogenesis of Gastrointestinal Tract.- AIB1: A Transcriptional Coactivator which Integrates Signaling Crosstalk in Cancer Cells.- Rational Design of DNA Anti-cancer Agent that Targets Signal Transducer and Activator of Transcription 3 (Stat3) for Cancer Therapy.- Estrogen Receptor Signaling in Lung Cancer.- Microparticle Dissemination of Biological Activities: Implications for Cancer Biology.- Protein Kinase D Signaling in Cancer.- Cell Signaling and Cancer: Integrated, Fundamental Approach Involving Electron Transfer,Reactive Oxygen Species and Antioxidants.- PPARg, Thiazolidinediones, Lung Cancer.- Targeting Signal Transducer and Activator of Transcription (STAT) for Anti-Cancer Therapy.- Index  
 
   
   
    
   
   
    
 
   

Textul de pe ultima copertă

The abnormal behavior of all cancer cells regardless of cancer type is irregular cell signaling pathway activity. A mechanistic approach dealing with a fundamental and molecular view based signaling cascade are exciting and dynamic areas of cancer research. This book illuminates what we know, how we know and what remains to be discovered in this regard. The book explore and identify not only the key compounds of cell signaling pathway but also the interaction between them, the cross-talk. This book bring together up-to-date summaries of the signaling components that are likely to be used in diagnosis, prognosis and novel target for pharmaceutical intervention and therapeutic development and highlight the importance of molecular approach to clinical cancer research. A lot clinical trials and outcome are promising.
The translation of recent advance in the knowledge of intracellular signaling into the generation of innovative molecular targeted cancer therapy are essential features of this book. Goals are manifold such as, resensitise chemoresistant target, capitalize on different mechanism of action and gain an advantage in the identification of best combination of drugs to induce clinically relevant response. The expert review compile in this book is an invaluable resource for graduate researcher and established scientist working in cell biology, pharmacy, experimental and molecular therapeutics and molecular medicine.

Caracteristici

Identifies various signaling molecules like GRB2 growth factors, A1B1, STAT, TGFß
Provides a critical assessment of surrogate markers involved in the emergence and progression of cancer
Covers the basic principle that drive oncogenesis and pharmacological interventions that lead to therapies